The Sta'I', test is a technically simple test of thyroxine measurement, which apparently gives results in good agreement with those derived by radioimmunoassay in most patients. In pregnancy, however, falsely low serum thyroxine values were found with the Sta'I', test when compared with either a radioimmunoassay or the Thyopac-4 test. Detailed studies showed that the discrepancy resulted from the extraction technique used in the Sta'I', test, which appears to allow the patient's thyroxine binding proteins to remain in the assay system. Similar method discrepancies were observed in other clinical conditions associated with elevated thyroxine binding globulin concentration. This study, as well as being of practical clinical importance, has implications for the design of competitive protein binding tests of thyroid function.
The study originated from the finding of discrepant results in serum T4 measured by StaT 4 and radioimmunoassay in a pregnant patient attending the Thyroid Clinic at Glasgow Royal Infirmary. Consequently, further samples were obtained from euthyroid pregnant patients attending an antenatal clinic and subsequently the postnatal clinic at Glasgow Royal Maternity Hospital. Additional studies were performed with serum samples taken from patients with defined abnormalities of thyroid function who were attending the Thyroid Clinic at Glasgow Royal Infirmary.
Blood specimens were centrifuged within two hours ofremoval, and the serum was stored at -20°C prior to thyroxine estimation.
Methods

ESTIMATION OF SERUM THYROXINE
The StaT4 Kit (Oxford Laboratories, Foster City, California, USA) has been used for two years in one of our laboratories and during this time has proved to be a quick and reliable method for the determination of serum T4 in the vast majority of patients 208 Thyroxine (T4) is transported in blood bound to serum thyroxine binding globulin (TBG), thyroxine binding prealbumin (TBPA), and albumin. The binding of T4 to TBG exhibits the highest affinity, and there is a 1:1 ratio of hormone to binding site (Robbins, 1975; Gersheng et al., 1976) . It has been recognised for many years that there is an increase in TBG concentration during pregnancy and that this increase is responsible for the raised total thyroxine levels observed in the blood of pregnant women (Dowling et al., 1956; Robbins and Nelson, 1958) .
The measurement of thyroxine in serum is routinely carried out either by a competitive protein binding (CPB) method or by a specific radioimmunoassay, and the results obtained by each method are usually in good agreement. Discrepancies in the T" levels of pregnant women have been observed between radioimmunoassay and CPB StaT4 methods (Baird et al., 1977) .
The data presented in this paper were obtained after the estimation of serum T4 by radioimmunoassay and StaT 4 in pregnant patients, in nonpregnant controls, and in patients with defined thyroid pathology. The reasons for the discrepancies observed between the two methods were explored. StaT, in euthyroid, thyrotoxic, and pregnant patients 
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Serum thyroxlu (nmol/l) studied (normal range 60-141 nmol/l). Unlike most CPB methods StaT4 does not involve the precipitation of serum proteins by absolute alcohol but uses instead a T4 extractant, which consists of a buffered mixture of water, ethanol, and silica. In the presence of extractant the T4 dissociates from its serum binding proteins and is adsorbed on to the silica. The adsorbed hormone is eluted from the silica at a different pH, and the eluant is subjected to normal CPB methodology. The routine method of T4 estimation in our other laboratory is a semi-automated radioimmunoassay using a second antibody separation (Challand et al., 1975) . In routine use the interassay and intra-assay coefficients of variation are 7'7% and 3'5% respectively, with a laboratory normal range of 55-144 nmoi/i.
For a part of this study a third estimation of serum thyroxine concentration was obtained using another CPB method (Thyopac 4; Radiochemical Centre, Arnersham), which employs an alcohol precipitation of protein as the first step.
For statistical purposes Student's t test for paired observations was used. Table 2 demonstrate that, while there is good agreement between radioimmunoassay T4 and StaT4 values in non-pregnant, euthyroid patients and in thyrotoxic patients, the approximate 2:1 ratio of concentrations is again observed in the pregnant subjects. The nature of the discrepancy was clarified by determining the T4 levels in the same group of pregnant patients by Thyopac-4 as well as by the two other methods. The results presented in Table 3 show that radioimmunoassay and Thyopac-4 produced quantitatively similar serum T4 concentrations while the StaT4 method appeared consistently to underestimate the thyroxine present.
Results
In order to demonstrate that the discrepancy was Conclusive evidence for the StaT4 extraction of binding protein could be obtained only by the demonstration of bound tracer in the CPB system in the absence of added TBG. A modified competitive protein binding method was therefore employed. After StaT4 extraction of duplicate volumes of serum, taken from normal subjects and thyrotoxic patients and from pregnant patients before and six weeks after delivery, the T4 adsorbed to the silica StaT4 as the stage at which the discrepancy occurs since the T4 results obtained with the modified procedure and by radioimmunoassay are similar in both groups of patients.
If the StaT4 extraction step is unable to remove quantitatively the elevated total T4 levels found in pregnancy then the measured T4 levels would be lower than expected. However, this problem should be overcome by increasing the volume of extractant. Accordingly, a fixed volume (0,2 ml) of pregnancy serum was extracted with increasing volumes of StaT4 extractant, and the apparent T4level in the extraction medium was quantitated in the normal manner. It is apparent from the data in Table 6 that the measured T4 level decreased with increasing volumes of extractant, and this observation would contradict a theory of inefficient T4 extraction. Such information strongly supports the concept of 'extracted TBG' as the cause of the discrepancy since increased volumes of extractant would be expected to exacerbate the effect and in tum bring about an apparent reduction in the measured T4 level.
related to pregnancy, a group of 10 subjects had blood removed immediately before delivery and again six weeks postpartum at the regular postnatal clinic. Thyroxine estimations were made by both StaT4 and radioimmunoassay. The results presented in Table 4 demonstrate that the two methods were in agreement in the serum obtained postpartum while the familiar discrepancy was present in the same patients before delivery.
Having established that the discrepancy in T4 estimation was related to pregnancy, two possible explanations can be advanced. Firstly, pregnancy serum could contain a compound that interferes with either the extraction or binding processes of the StaT4 method or, alternatively, the elevated levels of TBG, known to occur in pregnancy, could themselves be responsible since partial extraction of this protein would augment the binding species present in the CPB reaction and so apparently reduce the T4 level measured.
The most obvious candidates for interfering substances are the steroid hormones whose concentrations are known to be greatly elevated in pregnancy serum. Accordingly, oestradiol (0-100 nmol/l) and progesterone (0-2 pomol/l) were added to pooled normal serum either alone or in combination, and the T4 level of the serum was determined by all three methods. The results obtained demonstrated that the measured concentration of T4 in the serum was unaffected by the presence of the added steroids and that the absolute levels of T4 were the same when quantitated by radioimmunoassay, StaT4, or Thyopac 4.
The next approach to the problem was to ascertain the step of the StaT4 procedure at which the discrepancyoccurred. A modified procedure was applied to a group of euthyroid non-pregnant subjects and to a group of pregnant patients, and the T4 levels obtained were compared with those derived by the normal StaT4 method and by radioimmunoassay. The modification consisted ofreplacing the extraction step of StaT4 with an alcohol precipitation although the binding reaction was left unaffected. The results shown in Table 5 Table 5 Comparison of serum thyroxine concentrations derived by radioimmunoassay, StaT., and modified StaT. in pregnant and non-pregnant was eluted with 1 ml of 0'05M barbitone buffer containing 2 x 10 4 cpm of ( 1251)-thyroxine in the presence or absence of 6 %pooled normal human serum.
After a 60 min incubation at 20 cC, 0'5 ml barbitone buffer containing 0·1 g Davex Ag-X2 (200-400 mesh, chloride form) resin was added to each tube. The tubes were mixed and centrifuged at 2000 rpm for 10 min. An aliquot ofthe supernatant was radioassayed, and the binding was expressed as a percentage of that obtained in the extracts of the StaT4 standards. The results shown in Fig. 1 indicate that the extent of binding in the absence of added TBG was comparable with that of the reference standard in the normal group, the thyrotoxic group, and the postpartum group but was significantly elevated in the pregnant group. This provides strong evidence for the increased extraction of T4-binding protein from pregnancy serum. When exogenous TBG was added to the modified CPB system the T4 results obtained for all four groups were not significantly different from those obtained in the same samples by the standard StaT4 method.
Since the cause of the discrepancy in T4estimation appears to be the extraction of TBG from pregnancy serum a similar discrepancy between radioimmunoassay and StaT4 might be expected in other clinical situations in which elevated TBG occurs. This pos- sibility was examined by determining the serum T4 levels, by both methods, in a group of 39 women who were taking the oral contraceptive pill, in a group of eight patients with acute intermittent porphyria, and in a group of three postmenopausal women receiving oestrogen therapy for the treatment of breast carcinoma. The results in Fig. 2 demonstrate that the mean thyroxine level of the oral contraceptive group was only 69·8 % of that obtained by radioimmunoassay (p < 0'001) while similar discrepancies were observed in the porphyries and in the women receiving oestrogen therapy.
Discussion
The discrepancy in serum thyroxine levels determined by StaT4 and by radioimmunoassay has been confirmed. The cause of the discrepancy appears to be the extraction from the pregnancy serum of T4binding proteins, presumably TBG, which subsequently interfere with the competitive proteinbinding step of the method. Supportive evidence for this conclusion was obtained by the demonstration of both a greater discrepancy when the volume of extractant was increased and variable binding of ( 1 25 1) thyroxine in StaT4 extracts of pregnancy serum even in the absence of added TBG. Conclusive evidence that TBG is the actual protein extracted would require its isolation and characterisation from a StaT4 extract of pregnancy serum. Since the levels of TBG necessary to cause interference in the normal CPB method would be very small such a direct demonstration is beyond the scope of present methods. However, further indirect support for the role of TBG in reducing the 'apparent' T4 concentration was obtained with the observation that the discrepancy of methods could also be seen in other clinical states in which elevated TBG levels are known to occur-patients on oral contraceptive therapy, women receiving oestrogen therapy for breast carcinoma, and patients suffering from acute intermittent porphyria (Hollander et al., 1967) .
The results presented in this paper indicate that the StaT4 kit is not suitable for the estimation of serum thyroxine in either pregnant subjects or in certain other groups of patients. The rapid extraction step is clearly too sensitive to the natural variations in the endogenous level of Ta-binding proteins. Such problems are not encountered in the Thyopac-4 CPB method since dissociation of T4 is achieved by denaturation of the endogenous T4-binding proteins. However, in the latter system the T4 result obtained can be affected by sample storage since lipolysis can lead to elevated levels of free fatty acids which are readily solubilised in the ethanol precipitantandwhich can interfere in the normal T4:TBG binding process (Liewendahl and Helenius, 1976) . Since no serum extraction is necessary in the radioimmunoassay of thyroxine the results obtained are quite unaffected by the conditions of sample storage and appear to be independent of the levels of TBG encountered in all normal physiological conditions although the latter statement assumes that optimal concentrations of the TBG blocking agent, 8-anilino-1-naphthalene sulphonic acid, are employed (Burr et al., 1977) . Radioimmunoassay would, therefore, seem to offer the most reliable of the methods studied for the determination of serum total thyroxine.
